SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-23-002462
Filing Date
2023-11-06
Accepted
2023-11-06 13:47:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d07422pnt_11062023.htm SC 13D 308109
2 JOINT FILING AGREEMENT ex991to13d07422pnt_11062023.htm EX-99.1 8071
  Complete submission text file 0000921895-23-002462.txt   317815
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91575 | Film No.: 231379370
SIC: 2834 Pharmaceutical Preparations